Guidance on applications for COVID-19 drug...
Dataset description:
This section of the guidance outlines the additional requirements for good clinical practices, qualified investigators, and labelling.
There are no views created for this dataset yet.
Additional Information
| Field | Value |
|---|---|
| Data last updated | October 22, 2024 |
| Metadata last updated | October 22, 2024 |
| Created | October 22, 2024 |
| Format | HTML |
| License | Open Government Licence - Canada |
| Has views | False |
| Id | d77bcf15-7e59-45f8-8c70-f7be520651eb |
| Package id | 57ffff4a-39c1-47b6-89be-da7725fd0883 |
| Position | 0 |
| State | active |